Post-transcriptional regulation of P21WAF1/CIP1 by P53
Tóm tắt
Objective: To investigate the post-transcriptional regulation of p21WAF1/CIP1 by p53. Methods: The MDA-MB-468 cells have endogenous mutant p53 and the MCF7 cells lines have wtp53. Recombinant p53 expression and p21WAF1/CIP1 induction were detected by Western blot analysis. Northern blot analysis was carried out to examine whether changes in p21WAF1/CIP1 protein levels in MCF7 cells treated with AdCMVp53 are reflected at the mRNA level. Flow cytometric analysis of MCF7 cells following overexpression of recombination. Results: The ratio of p53: p21WAF1/CIP1 was below 1 at the early stages of AdCMVp53 infection, but increased to 1.6 by day 3 and to 9.7 by day 5 post-infection. As expected, p21WAF1/CIP1 expression was not detectable in MDA-MB-468 cells despite the presence of high levels of mutant p53 protein. The G1/S ratios in untreated controls and AdCMVβgal infected MCF7 cells were 1.10 and 1.35, respectively. By Northern blot analyzing the p21WAF1/CIP1: GAPDH ratios at different time points against the ratio at time point 0, a maximum 3-fold induction of p21WAF1/CIP1 mRNA expression relative to untreated control was observed on day 1 post-infection. The flow cytometric analysis indicated that MCF7 cells infected with AdCMVp53 undergo G1 arrest at both time points studied, with G1/S ratios ranging from 5.54 at day 1 to 5.65 at day 7. The G1/S ratios in untreated controls and AdCMVβgal infected MCF7 cells were 1.10 and 1.35, respectively. Conclusion: This study demonstrated that p53 could regulate p21WAF1/CIP1 gene expression at both the transcriptional and post-transcriptional levels in MCF7 cells. The latter mechanism may be involved in or be responsible for, the induction of cell cycle arrest by transcription-defective mutants of p53.
Tài liệu tham khảo
Akashi M, Osawa Y, Koeffler HP, et al. p21waf1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization[J]. Biochem J 1999; 337: 607.
Archer SY, Meng S, Shei A, et al. p21(waf1) is required for butyrate-mediated growth inhibition of human colon cancer cells[J]. Proc Natl Acad Sci USA 1998; 95:6791.
Butz K, Geisen C, Ullmann A, et al. Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress[J]. Oncpgene 1998; 17:781.
Cai K, Dynlacht BD. Activity and nature of p21(WAF1) Complexes during the cell cycle[J]. Proc Natl Acad Sci USA 1998; 95: 12254.
Cayrol C, Ducommun B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21[J]. Oncogene 1998; 17: 2437.
Elledge SJ, Harper JW. The role of protein stability in the cell cycle and cancer[J]. Biochim Biophys Acta 1998; 1377: M61.
Fernandes ER, Zhang JY, Rooney RJ, et al. Adenovirus E1A-regulated transcription factor p120E4F inhibits cell growth and induces the stabilization of cdk inhibitor p21WAF1[J]. Mol Cell Biol, 1998; 18: 459.
Gartel AL, Tyner AL. Transcriptional regulation of p21WAF1/CIP1 gene[J]. Exp Cell Res 1999; 246: 280.
Harvat BL, Wang A, Seth P, et al. Up-regulation of p27Kipl, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for,induction of squamous differentiation[J]. J Cell Sci 1998; 11:1185.
Johannessen LE, Knardal SL, Madshus IH, et al. Epidermal growth factor increases the level of the cyclin-dependent kinase(CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein[J]. Biochem J 1999; 337:599.